<DOC>
	<DOCNO>NCT01195207</DOCNO>
	<brief_summary>This phase 1 , safety study CNTO 3157 healthy subject subject asthma .</brief_summary>
	<brief_title>A Phase 1 Study CNTO 3157 Healthy Volunteers Patients With Asthma</brief_title>
	<detailed_description>A phase 1 , randomize ( study drug assign chance ) , double blind ( neither physician patient know CNTO 3157 placebo assign ) , placebo control , single , ascending-dose study CNTO 3157 healthy volunteer multiple dose study patient asthma . This study compare effect ( good bad ) CNTO 3157 placebo . The purpose study evaluate safety potential side effect CNTO 3157 give healthy volunteer patient asthma . In addition , investigator measure much study drug blood follow dose CNTO 3157 , determine body make antibody . ( An antibody protein make body response foreign substance ) . Safety assessment perform throughout study include obtain evaluate laboratory test , vital sign ( e.g. , blood pressure ) , occurrence severity adverse event . There 2 part study . The first part study involve healthy volunteer , second part study involve patient asthma . About 56 healthy volunteer 16 asthmatic patient take part . Volunteers require stay research center study agent administration inpatient portion study return require out-patient visit . Up approximately 8 different dose level study . CNTO 3157 administer IV infusion . The duration volunteer participation 21 week Part 1 24 week Part 2 .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>Healthy male female 18 55 year age inclusive clinically significant abnormality body weight 50 100 kg Patients asthma must diagnose least 6 month prior participation study Currently history clinically significant medical illness medical disorder investigator considers exclude subject , include ( limited ) cardiovascular disease , neuromuscular , hematological disease , immune deficiency state , respiratory disease ( asthma Part 2 ) , hepatic GI disease , neurological psychiatric disease , ophthalmological disorder , neoplastic disease , renal urinary tract disease , dermatological disease Have positive pregnancy test screen prior dose administration Have smoke tobacco relate product within 6 month prior dose Donated blood equal great Â¿450 mL within 60 day prior participation study Recent history ( within previous 6 month ) alcohol drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>CNTO 3157</keyword>
	<keyword>healthy volunteer</keyword>
	<keyword>asthma</keyword>
</DOC>